(2020) Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN). J Cancer Res Clin Oncol 146(3), 749-759.
PD Dr. med. Annamaria BrioliAlumni
(2019) The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey. Ann Hematol 98(3), 713-722.
(2017) Safety issues and management of toxicities associated with new treatments for multiple myeloma. Expert Rev Hematol 10(3), 193-205. (Review)